Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Fianlimab + Cemiplimab for Non-Small Cell Lung Cancer
Recruiting0 awardsPhase 2 & 3
Saint Petersburg, Florida
This trial is researching the effectiveness of two experimental drugs to treat advanced non-small cell lung cancer. It will also look at potential side effects and how it could improve quality of life.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.